US CPI rises slightly less-than-expected in July

Alexander Bueso Sharecast | 11 Aug, 2017 13:47 - Updated: 16:05 | | |

cbfedtiposinteres

The cost of living in the States increased at a slightly lower-than-expected pace last month as the cost of energy and that of cars and trucks fell.

Headline consumer prices in the US advanced by 0.1% month-on-month in July and were up by 1.7% year-on-year, according to the Bureau of Labor Statistics.

That was less than the 0.2% on the month (1.8% year-on-year) gains economists had penciled in.

At the 'core' level, CPI was up by identical magnitudes, in-line with forecasts.

Whereas food prices rose by 0.2% in comparison to June, energy prices dipped by a tenth of a percentage point.

Also weighing on the headline CPI index, prices for new vehicles and those for cars and trucks both weakened by 0.5% on the month.

Heading the other way, the cost of medical care services jumped by 0.3%, alongside a 1.0% rise in that for medical care commodities.

"Although the weakness in some of the components is likely to be temporary, we think the downward trend in core services and in particular shelter may be longer lasting and will make it harder for inflation to accelerate at a fast pace next year once the base effects from the weak Q2 prints are behind us," said Blerina Uruci at Barclays Research.

More news

17 Oct US close: Markets finish higher amid busy earnings season

US markets finished in the green on Tuesday, with the Dow closing just short of the 23,000 mark which it breached for the first time ever earlier in the session, amid a busy third quarter earnings season on Wall Street.

17 Oct Europe close: Stocks slip ahead of US Fed Beige Book

Stocks on the Continent finished slightly lower as investors bid their time ahead of the release of the US central bank's Beige Book on Wednesday, against the backdrop of fresh intra-day records on Wall Street's main benchmarks with the Dow Industrials having climbed above the 23,000 point mark for the first time ever.

17 Oct Buy Spain as political risk is 'overstated' - Credit Suisse

Spanish equities look unusually cheap, said Credit Suisse on Tuesday, as political risk is "overstated" and the country is on track for at least 3% growth, with employment, housing and construction all on a growth tear.

17 Oct London close: Stocks move lower even as Sterling slips

London stocks closed lower on Tuesday even as the pound fell back against the dollar, albeit following a brief pop higher after data showed inflation surged to a five-year high last month, amid somewhat dovish remarks from Bank of England policymakers.

17 Oct Director dealings: Beazley executive director sells after profit warning

Adrian Cox, executive director of risk insurance and reinsurance group Beazley, sold 180,009 shares in the company on Tuesday at the price of 500p per share.

17 Oct Credit Suisse cuts Tate and Lyle's target price, reiterates 'neutral' rating

Ahead of Tate & Lyle's interim results on 2 November, Credit Suisse updated its forecasts and cut its target price to 710p while reiterating its 'neutral' rating.

17 Oct US open: Dow Industrials clambers atop 23,000 mark for first time

The Dow Industrials climbed past the 23,000 points mark for the first time ever, as the third-quarter earnings season got into full swing, and then slipped lower.

17 Oct Higher inflation means benefits pain for households, says IFS

State benefits for roughly 10m UK families will be reduced by £450 a year in real terms after inflation reached its highest level in five years on Tuesday, the Institute for Fiscal Studies calculated.

17 Oct FTSE 250 movers: Virgin Money gains on update, Workspace boosted by JPM note

London's FTSE 250 was down 0.4% to 20,140.65 in afternoon trade on Tuesday.

17 Oct Johnson and Johnson raises full year targets after strong third quarter

Healthcare giant Johnson and Johnson posted higher than expected profits for the three months to 30 September thanks to increased demand for its new cancer drugs and the additional revenue afforded to the group from its June acquisition of Swiss biotech company Actelion.